Literature DB >> 457277

Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.

H Ohkuni, Y Norose, M Ohta, M Hayama, Y Kimura, M Tsujimoto, S Kotani, T Shiba, S Kusumoto, K Yokogawa, S Kawata.   

Abstract

This paper is concerned with the adjuvant activity in stimulatory immunoglobulin E production against ovalbumin (OA) by bacterial cell walls, cell wall peptidoglycan (PG), and their PG fragments and synthetic N-acetylmuramyl (MurNAc) dipeptides in A/J mice. A PG isolated from Streptococcus pyogenes, PG subunit polymer and dimer obtained from Staphylococcus epidermidis, and water-soluble fragments of cell walls or PG prepared from Nocardia corynebacteriodes and Streptomyces gardneri were found to enhance both the primary and secondary responses of anti-OA immunoglobulin E antibody production. It was suggested that the PG portion, either intact or highly degraded, was capable of enhancing the immunoglobulin E antibody production, and there was no need for the non-PG moiety or intactness of PG structure for the adjuvant activity. This finding was confirmed and extended by the use of synthetic MurNAc dipeptides. Among eight MurNAc dipeptides tested, MurNAc-l-Ala-d-isoGln, MurNAc-l-Ala-d-Gln, MurNAc-l-Ala-d-Glu, and MurNAc-l-Ser-d-isoGln were found active as an adjuvant in the stimulation of the primary and secondary reaginic anti-OA antibody production in a similar way to the cell wall PG and their fragments. None of the synthetic MurNAc-l-Ala-l-isoGln, MurNAc-l-Ala-l-Gln, MurNAc-l-Ala-l-Glu, and MurNAc-l-Ala-d-isoAsn, on the other hand, stimulated the anti-OA immunoglobulin E antibody production in either primary or secondary response, indicating the importance for the adjuvancy in immunoglobulin E production of the configuration of the glutamic acid residues adjacent to the l-Ala (or l-Ser) in muramyl dipeptides.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457277      PMCID: PMC414303          DOI: 10.1128/iai.24.2.313-318.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers.

Authors:  A Adam; M Devys; V Souvannavong; P Lefrancier; J Choay; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1976-09-07       Impact factor: 3.575

Review 2.  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.

Authors:  L Chedid; F Audibert; A G Johnson
Journal:  Prog Allergy       Date:  1978

3.  Structural specificity of synthetic peptide adjuvant for induction of experimental allergic encephalomyelitis.

Authors:  Y Nagai; K Akiyama; S Kotani; Y Watanabe; T Shimono; T Shiba; S Kusumoto
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

4.  Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse. A potential mouse model for immune aspects of human atopic allergy.

Authors:  B B Levine; N M Vaz
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

5.  Adjuvant activities in production of reaginic antibody in mice of bacterial cell wall peptidoglycans or peptidoglycan subunits and of synthetic N-acetylmuramyl dipeptides.

Authors:  H Ohkuni; Y Norose; M Hayama; Y Kinura; S Kotani; T Shiba; S Kusumoto; K Yologawa; S Kawata
Journal:  Biken J       Date:  1977-12

6.  Increased capillary permeability in guinea pigs and rats by peptidoglycan fraction extracted from Group A streptococcal cell walls.

Authors:  H Ohkuni; Y Kimura
Journal:  Exp Cell Biol       Date:  1976

7.  Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant.

Authors:  V Souvannavong; A Adam; E Lederer
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

8.  Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.

Authors:  A Tanaka; R Saito; K Sugiyama; I Morisaki; S Kotani
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

9.  Biological study of a nontoxic, water-soluble immunoadjuvant from mycobacterial cell walls.

Authors:  L Chedid; M Parant; F Parant; R H Gustafson; F M Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

10.  The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera.

Authors:  S V BOYDEN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

View more
  5 in total

Review 1.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

2.  Effects of multiple oral dosing on IgE synthesis in mice: oral sensitization by albumin extracts from seeds of Jack fruit (Artocarpus integrifolia) containing lectins.

Authors:  N Restum-Miguel; A Prouvost-Danon
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

3.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Comparison of effects of adjuvants on efficacy of virion envelope herpes simplex virus vaccine against labial infection of BALB/c mice.

Authors:  T A Thomson; J Hilfenhaus; H Moser; P S Morahan
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

5.  Investigation of chemical transformations of thiophenylglycoside of muramyl dipeptide on the fumed silica surface using TPD-MS, FTIR spectroscopy and ES IT MS.

Authors:  Liana R Azizova; Tetiana V Kulik; Borys B Palianytsia; Aleksandr E Zemlyakov; Viktoriya N Tsikalova; Vasiliy Ya Chirva
Journal:  Nanoscale Res Lett       Date:  2014-05-13       Impact factor: 4.703

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.